Chromosomal abnormalities are often detected in women with reproductive problems. This study aimed to investigate the presence and type of chromosomal aberrations in peripheral blood of women undergoing in vitro fertilization (IVF) and their possible association with advanced maternal age (AMA). A total of 1,837 women undergoing IVF between 2016 and 2019 were enrolled in the study. Women were further divided in AMA (≥35 years) and younger women (<35 years). Chromosomal abnormalities were detected by peripheral blood karyotyping using standard cytogenetic techniques. Chromosomal abnormalities were detected in 13.5% of the enrolled women; 1.1% had autosomal abnormalities including reciprocal translocations, inversions, Robertsonian translocations, and a supernumerary marker chromosome, while 12.4% had X chromosome abnormalities. The frequency of chromosomal abnormalities was significantly higher in AMA women than in younger ones (17.4% vs. 3.9%, p < 0.05). Women of AMA exhibited X chromosome mosaicism with a frequency of 16.1%, and mosaic karyotypes with 2 and 3 aneuploid cell lines were more frequently detected. X chromosome mosaicism is the most common karyotypic aberration in women undergoing IVF and has 6-fold increased incidence in AMA women compared to younger ones. The present study verifies previous observations that low-level peripheral blood X chromosome mosaicism and the number of aneuploid cell lines observed in women of AMA could be an indication of aneuploidy and poor quality of oocytes contributing to infertility.

1.
Baronchelli
S
,
Conconi
D
,
Panzeri
E
,
Bentivegna
A
,
Redaelli
S
,
Lissoni
S
,
Cytogenetics of premature ovarian failure: an investigation on 269 affected women
.
J Biomed Biotechnol
.
2011
;
2011
:
370195
.
2.
Burgoyne
PS
,
Baker
TG
.
Meiotic pairing and gametogenic failure
.
Symp Soc Exp Biol
.
1984
;
38
:
349
62
.
3.
Capalbo
A
,
Hoffmann
ER
,
Cimadomo
D
,
Ubaldi
FM
,
Rienzi
L
.
Human female meiosis revised: new insights into the mechanisms of chromosome segregation and aneuploidies from advanced genomics and time-lapse imaging
.
Hum Reprod Update
.
2017
;
23
:
706
22
. .
4.
Capkova
P
,
Santava
A
,
Krskova
M
,
Adamova
K
,
Hladikova-Zborilova
B
,
Nedomova
R
,
Low-Level Gonosomal Mosaic (LLGM) In Female Reproduction
.
Obstet Gynecol
.
2014
;
884168
.
5.
Chamani
IJ
,
Keefe
DL
.
Epigenetics and Female Reproductive Aging
.
Front Endocrinol (Lausanne)
.
2019
;
10
:
473
. .
6.
Cimadomo
D
,
Fabozzi
G
,
Vaiarelli
A
,
Ubaldi
N
,
Ubaldi
FM
,
Rienzi
L
.
Impact of Maternal Age on Oocyte and Embryo Competence
.
Front Endocrinol (Lausanne)
.
2018
;
9
:
327
. .
7.
Devi
AS
,
Metzger
DA
,
Luciano
AA
,
Benn
PA
.
45,X/46,XX mosaicism in patients with idiopathic premature ovarian failure
.
Fertil Steril
.
1998
;
70
:
89
93
. .
8.
Fitzgerald
PH
.
A mechanism of x chromosome aneuploidy in lymphocytes of aging women
.
Humangenetik
.
1975
;
28
:
153
8
. .
9.
Franasiak
JM
,
Forman
EJ
,
Hong
KH
,
Werner
MD
,
Upham
KM
,
Treff
NR
,
The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening
.
Fertil Steril
.
2014
;
101
:
656
63
.
10.
Greaney
J
,
Wei
Z
,
Homer
H
.
Regulation of chromosome segregation in oocytes and the cellular basis for female meiotic errors
.
Hum Reprod Update
.
2017
;
24
:
135
61
. .
11.
Guttenbach
M
,
Koschorz
B
,
Bernthaler
U
,
Grimm
T
,
Schmid
M
.
Sex chromosome loss and aging: in situ hybridization studies on human interphase nuclei
.
Am J Hum Genet
.
1995
;
57
:
1143
50
.
12.
Hassold
T
,
Hall
H
,
Hunt
P
.
The origin of human aneuploidy: Where we have been, where we are going
.
Hum Mol Genet
.
2017
;
16 Spec No. 2
:
R203
8
. .
13.
Kalmbach
KH
,
Fontes Antunes
DM
,
Dracxler
RC
,
Knier
TW
,
Seth-Smith
ML
,
Wang
F
,
Telomeres and human reproduction
.
Fertil Steril
.
2013
;
99
:
23
9
.
14.
Lakhal
B
,
Braham
R
,
Berguigua
R
,
Bouali
N
,
Zaouali
M
,
Chaieb
M
,
Cytogenetic analyses of premature ovarian failure using karyotyping and interphase fluorescence in situ hybridization (FISH) in a group of 1000 patients
.
Clin Genet
.
2010
;
78
:
181
5
. .
15.
Madan
K
,
Lundberg
E
.
Low grade mosaicism for X aneuploidy in women referred for recurrent abortions
.
European Cytogenetisists Association (ECA) Newsletter
.
2015
;
35
:
9
12
.
16.
McGowan-Jordan
J
,
Hastings
RJ
,
Moore
S
, editors.
ISCN 2020: An International System for Human Cytogenomic Nomenclature
.
Basel, S. Karger
;
2020
.
17.
Nowinski
GP
,
Van Dyke
DL
,
Tilley
BC
,
Jacobsen
G
,
Babu
VR
,
Worsham
MJ
,
The frequency of aneuploidy in cultured lymphocytes is correlated with age and gender but not with reproductive history
.
Am J Hum Genet
.
1990
;
46
:
1101
11
.
18.
Nussbaum
RL
,
McInnes
RR
,
Willard
HF
.
Principles of clinical cytogenetics and genome analysis
. In: Thompson & Thompson Genetics in Medicine.
Philadelphia (PA)
:
Elsevier
;
2016
. p.
57
74
.
19.
Russell
LM
,
Strike
P
,
Browne
CE
,
Jacobs
PA
.
X chromosome loss and ageing
.
Cytogenet Genome Res
.
2007
;
116
:
181
5
. .
20.
Zachaki
S
,
Kouvidi
E
,
Pantou
A
,
Tsarouha
H
,
Mitrakos
A
,
Tounta
G
,
Low-level X Chromosome Mosaicism: A Common Finding in Women Undergoing IVF
.
In Vivo
.
2020
;
34
:
1433
7
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.